What are the signs and symptoms of splenic infarction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Splenic Infarction

Splenic infarction presents with left upper quadrant abdominal pain in approximately 70-80% of cases, though a substantial minority (20-31%) remain completely asymptomatic, making clinical diagnosis challenging. 1, 2, 3

Clinical Presentation

Primary Symptoms

  • Left upper quadrant or left flank pain is the most common presenting symptom, occurring in 70-80% of patients 1, 3
  • Fever and chills are present in approximately 36-70% of cases, particularly common in patients with embolic etiologies (70%) 2, 4
  • Constitutional symptoms including malaise and generalized weakness may accompany the acute presentation 4
  • Asymptomatic presentation occurs in 20-31% of patients, often discovered incidentally on imaging performed for other reasons 2, 5

Physical Examination Findings

  • Left upper quadrant tenderness is the most common physical finding, present in 35-36% of patients 2, 3
  • Peritoneal friction rub over the spleen, while classically described by Osler, is rarely encountered in contemporary practice 2
  • Splenomegaly may be palpable depending on the underlying etiology and extent of infarction 6
  • Absence of localized signs occurs in approximately 31% of cases, making physical examination unreliable as a sole diagnostic tool 2

Laboratory Abnormalities

Hematologic Markers

  • Leukocytosis with neutrophilia is common, present in 56-75% of cases, with a concurrent decrease in lymphocyte counts 1, 2
  • Anemia is frequently observed in patients with splenic infarction 1
  • Thrombocytosis may be present, particularly in patients with underlying hematologic malignancies 7

Biochemical Markers

  • Markedly elevated lactate dehydrogenase (LDH) is present in 71% of cases and serves as a useful diagnostic marker 1, 2
  • Elevated C-reactive protein (CRP) is remarkably increased in most patients 1
  • Hypoalbuminemia is commonly observed 1
  • Liver dysfunction with elevated transaminases may be present 1

Coagulation Abnormalities

  • Decreased fibrinogen levels are characteristic findings 1
  • Markedly elevated D-dimer is consistently observed 1
  • Prolonged activated partial thromboplastin time may be present and correlates with worse prognosis 1

Clinical Context and Risk Factors

Common Underlying Conditions

  • Hematologic malignancies account for a significant proportion of cases (33-59% in various series), including chronic myeloid leukemia, lymphoma, and other myeloproliferative disorders 1, 7, 4
  • Cardioembolic sources including atrial fibrillation (22%) and intracardiac thrombus are frequent etiologies 1, 2
  • Infections including bacterial endocarditis (though less common than historically described) and COVID-19 (increasingly recognized) 1, 5
  • Solid malignancies with metastatic potential (melanoma, breast, lung, ovarian cancer) 6, 5

Prognostic Indicators

Laboratory parameters that predict mortality include: leukocytosis, decreased lymphocytes, prolonged aPTT, decreased fibrinogen, elevated transaminases, elevated LDH, and elevated blood urea nitrogen 1

Overall mortality in contemporary series ranges from 5-33%, with one-third of patients dying in recent cohorts 1, 4

Diagnostic Imaging Characteristics

  • Contrast-enhanced CT scan is the gold standard, demonstrating wedge-shaped or focal hypodense areas in the spleen 6, 4, 3
  • Ultrasound is diagnostic in only 18% of cases and should not be relied upon for definitive diagnosis 3
  • Doppler ultrasound can assess splenic vascularization but has limited sensitivity 8

Critical Clinical Pitfalls

  • Do not dismiss the diagnosis in asymptomatic patients—nearly one-third have no localizing symptoms, and splenic infarction may be the presenting sign of serious underlying disease (bacterial endocarditis, hematologic malignancy, or thromboembolic disorder) in 17-22% of cases 2, 3
  • Fever without abdominal pain should still prompt consideration of splenic infarction, particularly in patients with known embolic risk factors 2, 4
  • Single infarcts are more likely to present with fever (63%) and leukocytosis compared to multiple infarcts 2
  • Surgical complications including splenic abscess and rupture can occur and require vigilant monitoring 4

References

Research

Splenic infarction: an update on William Osler's observations.

The Israel Medical Association journal : IMAJ, 2010

Research

Splenic infarction: 10 years of experience.

The American journal of emergency medicine, 2009

Research

The clinical spectrum of splenic infarction.

The American surgeon, 1998

Guideline

Evaluation and Management of Small (≈1.3 cm) Splenic Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Suspected Splenomegaly in a Stable Patient

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.